Title

Conformational Analysis of Neomycin B and Its Derivative

Poster Number

09B

Lead Author Major

Biochemistry

Lead Author Status

Senior

Format

Poster Presentation

Faculty Mentor Name

Andreas Franz

Faculty Mentor Email

afranz@pacific.edu

Faculty Mentor Department

Chemistry

Additional Faculty Mentor Name

Liang Xue

Additional Faculty Mentor Email

lxue@pacific.edu

Additional Faculty Mentor Department

Chemistry

Graduate Student Mentor Name

Amelia Watson

Graduate Student Mentor Email

a_watson4@u.pacific.edu

Graduate Student Mentor Department

Chemistry

Additional Mentors

Graduate Student Mentor

Anoopjit Singh Kooner

a_kooner@u.pacific.edu

Chemistry

Abstract/Artist Statement

Neomycin B is an aminoglycoside antibiotic, topically used to prevent and treat infections. When ingested, Neomycin cannot be absorbed by the intestine and therefore can be prescribed during liver failure or before GI surgery to keep ammonia levels and bacterial levels low and prevent hepatic encephalopathy, which is loss of brain function due to a buildup of toxins. Neomycin B binds to a specific protein in the bacterial ribosome and interferes with bacterial protein synthesis, which leads to destruction of the bacterium. In addition, neomycin B is known to bind to RNA as well as triple-strand-DNA. The exact location of binding in the latter case is not known and is subject to ongoing research in multiple groups. The effectiveness of binding (matched molecular “handshake” or “key-lock” match) is dependent on neomycin’s solution conformation. Even if new chemical structure is added to neomycin (“key chain”), neomycin’s structure (“key”) must remain unaltered to fit the binding site (“lock”). The objective of this project was to characterize the solution geometry of neomycin B and an EDTA-derivative thereof. To our knowledge, neomycin has not been fully characterized in recent years. Quantitative information about its conformation in solution and the effects of attached substituents on the structure guides scientists in deciphering neomycin’s mode of action. In the present work, complete conformational analysis was accomplished by nuclear magnetic resonance (NMR) spectroscopy and molecular dynamics (MD) simulations. We assigned all 1H-, 13C, and 15N-resonances unambiguously, confirmed by short- and long-distance correlations. Quantitative coupling constants and qualitative 1H-1H-distances were extracted from J-resolved HMBC and NOE experiments. The compounds 2-(hydroxymethyl)-tetrahydrofuran and D-ribose were used as model compounds before analyzing neomycin and its EDTA-derivative. MD simulations were carried out in AMBER 14 with the GLYCAM06 force field. Preliminary data indicated that experimental and computational data agree well.

Location

DeRosa University Center, Ballroom

Start Date

29-4-2017 1:00 PM

End Date

29-4-2017 3:00 PM

This document is currently not available here.

Share

COinS
 
Apr 29th, 1:00 PM Apr 29th, 3:00 PM

Conformational Analysis of Neomycin B and Its Derivative

DeRosa University Center, Ballroom

Neomycin B is an aminoglycoside antibiotic, topically used to prevent and treat infections. When ingested, Neomycin cannot be absorbed by the intestine and therefore can be prescribed during liver failure or before GI surgery to keep ammonia levels and bacterial levels low and prevent hepatic encephalopathy, which is loss of brain function due to a buildup of toxins. Neomycin B binds to a specific protein in the bacterial ribosome and interferes with bacterial protein synthesis, which leads to destruction of the bacterium. In addition, neomycin B is known to bind to RNA as well as triple-strand-DNA. The exact location of binding in the latter case is not known and is subject to ongoing research in multiple groups. The effectiveness of binding (matched molecular “handshake” or “key-lock” match) is dependent on neomycin’s solution conformation. Even if new chemical structure is added to neomycin (“key chain”), neomycin’s structure (“key”) must remain unaltered to fit the binding site (“lock”). The objective of this project was to characterize the solution geometry of neomycin B and an EDTA-derivative thereof. To our knowledge, neomycin has not been fully characterized in recent years. Quantitative information about its conformation in solution and the effects of attached substituents on the structure guides scientists in deciphering neomycin’s mode of action. In the present work, complete conformational analysis was accomplished by nuclear magnetic resonance (NMR) spectroscopy and molecular dynamics (MD) simulations. We assigned all 1H-, 13C, and 15N-resonances unambiguously, confirmed by short- and long-distance correlations. Quantitative coupling constants and qualitative 1H-1H-distances were extracted from J-resolved HMBC and NOE experiments. The compounds 2-(hydroxymethyl)-tetrahydrofuran and D-ribose were used as model compounds before analyzing neomycin and its EDTA-derivative. MD simulations were carried out in AMBER 14 with the GLYCAM06 force field. Preliminary data indicated that experimental and computational data agree well.